| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ACTU returned -85.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -79.6% |
| 1 year | -85.0% |
| All-time high | $11.90 (May 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ACTU would be worth today ›No. Actuate Therapeutics, Inc. Common stock has not paid a dividend in the past 12 months.
Actuate Therapeutics, Inc. Common stock stock trades on NASDAQ under the ticker symbol ACTU.
Actuate Therapeutics, Inc. Common stock is part of the Healthcare sector.
Actuate Therapeutics, Inc. Common stock has a market cap of 30.02M USD, based on the latest quote.
Actuate Therapeutics, Inc. Common stock is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
